|
membrane fusion
|
GO:0061025 |
38 |
0.273
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.247
|
|
|
pma inducible membrane protein ectodomain proteolysis
|
GO:0051088 |
1 |
0.128
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.122
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.115
|
Human |
|
regulation of protein localization
|
GO:0032880 |
231 |
0.114
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.111
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.107
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.106
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.094
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.091
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.090
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.090
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.086
|
Human |
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.076
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.074
|
Human |
|
membrane organization
|
GO:0061024 |
245 |
0.072
|
|
|
wax biosynthetic process
|
GO:0010025 |
2 |
0.071
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.069
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.068
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.066
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.064
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.063
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.062
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.062
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.061
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.060
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.057
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.057
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.056
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.053
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.053
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.052
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.051
|
Human |
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.049
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.048
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.047
|
Human |
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.047
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.046
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.046
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.045
|
Human |
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.043
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.042
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.042
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.041
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.040
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.040
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.040
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.039
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.039
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.039
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.037
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
Human |
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.037
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.036
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.036
|
Human |
|
protein polymerization
|
GO:0051258 |
57 |
0.036
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.036
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.036
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.035
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.035
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.034
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.033
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.033
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.033
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
protein refolding
|
GO:0042026 |
1 |
0.031
|
|
|
regulation of protein targeting to membrane
|
GO:0090313 |
9 |
0.031
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.031
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.030
|
Human |
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.030
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.029
|
Human |
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.029
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.029
|
Human |
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.029
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.029
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.029
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.028
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.028
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.028
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
Human |
|
calcium ion transport
|
GO:0006816 |
159 |
0.027
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.027
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.027
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.027
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.027
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.026
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.026
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.025
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.025
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.025
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.025
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.025
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.025
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.025
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.025
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.025
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.025
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.025
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.024
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.024
|
Human |
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.024
|
|
|
nucleotide transmembrane transport
|
GO:1901679 |
2 |
0.024
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.024
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.023
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.023
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.023
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.023
|
Human |
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
Human |
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.022
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.022
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.022
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.022
|
Human |
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.022
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.021
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.021
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
Human |
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
Human |
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.020
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.020
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.020
|
Human |
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.020
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.020
|
Human |
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.020
|
|
|
nucleotide sugar transport
|
GO:0015780 |
2 |
0.019
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.019
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
Human |
|
endomembrane system organization
|
GO:0010256 |
147 |
0.019
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.019
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
Human |
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.019
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
Human |
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.019
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.019
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.018
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.018
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
Human |
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.018
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.018
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
Human |
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.017
|
Human |
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.017
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
Human |
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.017
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
Human |
|
response to oxidative stress
|
GO:0006979 |
123 |
0.017
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.017
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.017
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.017
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.017
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.017
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.016
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.016
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.016
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.016
|
|
|
wound healing
|
GO:0042060 |
157 |
0.016
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.016
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.016
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
Human |
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.016
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.016
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.016
|
Human |
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.016
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.016
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.016
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.016
|
|
|
bone development
|
GO:0060348 |
120 |
0.016
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.016
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.016
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.016
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.015
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.015
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.015
|
Human |
|
cytokinetic process
|
GO:0032506 |
2 |
0.015
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
regulation of membrane lipid distribution
|
GO:0097035 |
16 |
0.015
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.015
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.014
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.014
|
Human |
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.014
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.014
|
Human |
|
cytokinesis
|
GO:0000910 |
17 |
0.014
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.014
|
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
4 |
0.014
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.014
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.014
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.014
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.014
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.014
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.014
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.014
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.014
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.014
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.014
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.014
|
|
|
defecation
|
GO:0030421 |
1 |
0.014
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.014
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.014
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.014
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.014
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.014
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
Human |
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.013
|
Human |
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.013
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.013
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.013
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.013
|
Human |
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.013
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.013
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.013
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.013
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.013
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.013
|
Human |
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.013
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.013
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.013
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.013
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.013
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.013
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.013
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
Human |
|
protein depolymerization
|
GO:0051261 |
34 |
0.013
|
|
|
negative regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902443 |
3 |
0.013
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.013
|
Human |
|
locomotory behavior
|
GO:0007626 |
195 |
0.013
|
|
|
synaptic vesicle fusion to presynaptic membrane
|
GO:0031629 |
3 |
0.012
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.012
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.012
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.012
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
monoubiquitinated protein deubiquitination
|
GO:0035520 |
2 |
0.012
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
skin development
|
GO:0043588 |
220 |
0.012
|
|
|
transforming growth factor beta1 production
|
GO:0032905 |
3 |
0.012
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.012
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.012
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.012
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.012
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.012
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.012
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.012
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.012
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.012
|
Human |
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.012
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.012
|
Human |
|
sensory perception of touch
|
GO:0050975 |
2 |
0.011
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.011
|
|
|
action potential
|
GO:0001508 |
78 |
0.011
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.011
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.011
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.011
|
Human |
|
hippo signaling
|
GO:0035329 |
11 |
0.011
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.011
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.011
|
|
|
lipid translocation
|
GO:0034204 |
9 |
0.011
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.011
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.011
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.011
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.011
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.011
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.011
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.011
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.011
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.011
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.011
|
|
|
cell division
|
GO:0051301 |
120 |
0.011
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.011
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.011
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.011
|
|
|
negative regulation of calcium ion transmembrane transporter activity
|
GO:1901020 |
1 |
0.011
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.011
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.011
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.011
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.011
|
|
|
synaptic vesicle priming
|
GO:0016082 |
8 |
0.011
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.011
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.010
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.010
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.010
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.010
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.010
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.010
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.010
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.010
|
|
|
amp biosynthetic process
|
GO:0006167 |
2 |
0.010
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.010
|
Human |
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.010
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.010
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.010
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.010
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.010
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.010
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.010
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.010
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.010
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.010
|
|
|
regulation of apoptotic dna fragmentation
|
GO:1902510 |
5 |
0.010
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.010
|
|